Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: a single center experience

Background Pulmonary disorders and respiratory failure represent one of the most common morbidities of preterm newborns admitted to neonatal intensive care units (NICUs). The use of nasal high-flow therapy (nHFT) has been more recently introduced into the NICUs as a non-invasive respiratory (NIV) support. Methods We performed a retrospective study to evaluate safety and effectiveness of nHFT as primary support for infants born